This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
Skip to main content
United Kingdom | EN-GB

Add a bookmark to get started

Cortex - Life Sciences Insights

| less than a minute read

2023 Global M&A Intelligence Report – Life Sciences Supplement

The DLA Piper Life Sciences sector team is delighted to announce the launch of our new 2023 Global M&A Intelligence Report – Life Sciences Supplement.

The Supplement – created by M&A professionals from across our global Life Sciences sector team – covers M&A deal activity in 2022 and supplements our 2023 global M&A Intelligence Report, which is now in its ninth edition.

The report looks at a selection of our international corporate life sciences transactions to identify trends and developments, which can provide insightful intelligence for those operating in the sector and considering M&A activity, both domestically or internationally.

Request the report

“Buyers and investors must pay close attention in conducting adequate regulatory due diligence, when evaluating targets in rapidly evolving environments.” Marco de Morpurgo, Global Co-Chair and EU Regulatory Lead – Life Sciences